Project code
|
Project Title
|
Commencement date
|
Value per week
|
Pre-requisite Units
|
Project Contact
|
| 1192 |
Defining subpopulations of pathogenic macrophages underlying lung diseases |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Margaret Hibbs Margaret.Hibbs@monash.edu |
| 1193 |
Targeted therapy in the treatment of autoimmunity |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Margaret Hibbs Margaret.Hibbs@monash.edu |
| 1194 |
Follicular helper T cells in antibody responses |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Di Yu Di.Yu@monash.edu |
| 1195 |
Interleukin-21 in antibody responses, anti-tumour responses and anti-infection responses |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Di Yu Di.Yu@monash.edu |
| 1196 |
The identification and characterisation of the major allergens in Australian crustacean species |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Jennifer Rolland Jennifer.Rolland@monash.edu |
| 1197 |
Mechanisms of immunological tolerance associated with transplantation of genetic manipulated bone marrow stem cells as a treatment for autoimmunity |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Frank Alderuccio frank.alderuccio@monash.edu |
| 1198 |
The role of BAFF in myeloid homeostasis |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Fabienne Mackay fabienne.mackay@monash.edu |
| 1199 |
The role of the BAFF system in modu-lting TH-17 cell function in autoimmune disease |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Fabienne Mackay fabienne.mackay@monash.edu |
| 1200 |
miRNAs and B cell activation |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Fabienne Mackay fabienne.mackay@monash.edu |
| 1201 |
Analysing the Phenotype of new tetraspanin-deficient mice |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Mark Wright mark.wright@med.monash.edu.au, |
| 1202 |
The role of tetraspanins in leucocyte recruitment |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Mark Wright mark.wright@monash.edu and Michael Hickey michael.hickey@monash.edu |
| 1203 |
Mechanisms of regulatory T cell (Treg) induction by ovarian cancer |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Magdalena Plebanski Magdalena.Plebanski@monash.edu |
| 1204 |
Using nano particles to prevent allergic airways inflammation |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Magdalena Plebanski Magdalena.Plebanski@monash.edu |
| 1205 |
Targeting human acute leukaemia with the novel immunomodulatory drug lenalidomide by boosting tumour necrosis factor (TNF) expressing immune cells |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Magdalena Plebanski Magdalena.Plebanski@monash.edu |
| 1206 |
Malaria nanovaccines |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Magdalena Plebanski Magdalena.Plebanski@monash.edu |
| 1207 |
Engaging nanotechnology to develop vaccines to prevent and treat cancer |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Magdalena Plebanski Magdalena.Plebanski@monash.edu |
| 1208 |
Characterization of novel suppressor T cells |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Magdalena Plebanski Magdalena.Plebanski@monash.edu |
| 1209 |
A novel T cell subset that does not fall into the conventional naïve and memory T cell paradigms |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Magdalena Plebanski Magdalena.Plebanski@monash.edu |
| 1210 |
Are epigenetic enzymes regulated in diabetic retinopathy? |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Antonia Miller Antonia.Miller@monash.edu |
| 1211 |
How do retinal microglia contribute to diabetic retinopathy |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Antonia Miller Antonia.Miller@monash.edu |
| 1212 |
Evaluating the contribution of ACE2 to diabetic retinopathy |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Jennifer Wilkinson- Berka Jennifer.Wilkinson-Berka@monash.edu |
| 1213 |
The expression and role of the renin-angiotensin system in the adaptive immune system and diabetic retinopathy |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Jennifer Wilkinson- Berka Jennifer.Wilkinson-Berka@monash.edu |
| 1214 |
Contribution of GPx1 to the Development of Diabetic Retinopathy |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Jennifer Wilkinson- Berka Jennifer.Wilkinson-Berka@monash.edu |
| 1215 |
Regulation of inflammation in health and disease by dietary molecules, microbiota and GPR43 |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Charles Mackay Charles.Mackay@monash.edu |
| 1216 |
Identifying novel genes in immune cell function |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Charles Mackay Charles.Mackay@monash.edu |
| 1217 |
The role of interleukin-21 in regulating inflammatory and autoimmune responses |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Charles Mackay Charles.Mackay@monash.edu |
| 1218 |
The role of dietary molecules, gut microbiota and GPR43 in colon tumorigenesis |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Charles Mackay Charles.Mackay@monash.edu |
| 1219 |
Diet and fatty acids as a basis for human disease |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Charles Mackay Charles.Mackay@monash.edu |
| 1220 |
The gut epithelium: one of the unexpected best targets to treat inflammatory diseases |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Charles Mackay Charles.Mackay@monash.edu |
| 1221 |
New engineered antibody based therapy for rheumatoid arthritis and related chronic inflammatory |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Charles Mackay Charles.Mackay@monash.edu |
| 1222 |
The effects of immunomodulatory products on the development of asthma |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Charles Mackay Charles.Mackay@monash.edu |
| 1223 |
The role of novel chemokine receptors in bacterial, viral and parasitic infection |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Charles Mackay Charles.Mackay@monash.edu |
| 1224 |
A strong gut feeling about the cause of Type 1 diabetes |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Eliana Marino Eliana.Marino@monash.edu |
| 1225 |
NKT cells: the bridge between type 1 diabetes and gut microbiota |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Eliana Marino Eliana.Marino@monash.edu
|
| 1226 |
Improving blood transfusion through innovative science |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Rosemary Sparrow rsparrow@redcrossblood.org.au
|
| 1227 |
Providing “help” for effective cancer immunotherapy |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Phil Darcy phil.darcy@petermac.org |
